In a case–control study comparing 21 CAD patients and 20 matched controls, CAD subjects exhibited significantly increased EAT resistin mRNA expression and decreased apelin mRNA, despite no differences in EAT volume or density across groups. Here, APLN is linked to coronary artery disorder.